Barely Significant
← all excerpts

Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.

J Am Heart Assoc · 2017 · PMC5721756 · PMID 29101117

2
hedged sentences
0.0770
closest p · 1.5× alpha
0.0770
boldest claim

The sentences

showed a trendP =0.077so close (0.05 < p ≤ 0.1)
Overall, nonsmokers, in comparison to current smokers, showed a trend for a higher rate of major bleedings (166 [1.5%] versus 71 [1.1%]; HR 1.32, 95% CI, 0.97–1.79, P =0.077), as displayed in Table 2 .

also in 53,322 other papers

highly significantno p-value reported
In comparison to non‐, light‐, and moderate smokers, heavy smokers (consuming ≥20 cigarettes/d) showed a highly significant reduction of the primary end point, the rates of MI and stent thrombosis ( P for all <0.0001), without relevant increase in bleeding risk, if treated with a double‐ compared with a standard‐dose clopidogrel regimen (Table 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.